Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
TIM SA
TIMB
$8.38B
| $3.09M | ﹤0.01% |
287,981
+59,840
| +26% | +$673K |
|
3377
Broadstone Net Lease
BNL
$4.32B
| $3.08M | ﹤0.01% |
124,101
+102,828
| +483% | +$2.66M |
|
3378
Omnicell
OMCL
$1.51B
| $3.08M | ﹤0.01% |
20,720
+6,784
| +49% | +$1.04M |
|
3379
State Street Blackstone Senior Loan ETF
SRLN
$5.48B
| $3.08M | ﹤0.01% |
66,809
-34,480
| -34% | -$1.58M |
|
|
BYTSU
3380
DELISTED
BYTE Acquisition Corp. Units
BYTSU
| $3.07M | ﹤0.01% |
307,701
-1,216,400
| -80% | -$12.1M |
|
|
SUMO
3381
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $3.07M | ﹤0.01% |
190,495
-236,433
| -55% | -$4.7M |
|
3382
Nicolet Bankshares
NIC
$3.6B
| $3.06M | ﹤0.01% |
41,297
+24,191
| +141% | +$1.77M |
|
|
TBI
3383
Trueblue
TBI
$326M
| $3.06M | ﹤0.01% |
113,018
-6,072
| -5% | -$162K |
|
|
AMTI
3384
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $3.06M | ﹤0.01% |
+118,164
| New | +$3.75M |
|
3385
Bright Horizons
BFAM
$3.64B
| $3.06M | ﹤0.01% |
21,914
+18,206
| +491% | +$2.67M |
|
|
TMPM
3386
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
| $3.05M | ﹤0.01% |
311,389
+255,035
| +453% | +$2.49M |
|
|
AESC
3387
DELISTED
The AES Corporation
AESC
| $3.05M | ﹤0.01% |
31,412
+19,964
| +174% | +$2.03M |
|
3388
iShares Core MSCI EAFE ETF
IEFA
$195B
| $3.04M | ﹤0.01% |
40,978
+34,978
| +583% | +$2.66M |
|
|
PWPPW
3389
CALL
DELISTED
Perella Weinberg Partners Warrant
PWPPW
| $3.04M | ﹤0.01% |
962,897
+391,534
| +69% | +$1.27M |
|
3390
Compass Minerals
CMP
$1.03B
| $3.04M | ﹤0.01% |
47,135
-26,170
| -36% | -$1.72M |
|
|
NP
3391
DELISTED
Neenah, Inc. Common Stock
NP
| $3.02M | ﹤0.01% |
64,808
-29,040
| -31% | -$1.42M |
|
3392
Veeco
VECO
$2.71B
| $3.02M | ﹤0.01% |
135,933
-47,811
| -26% | -$1.06M |
|
3393
ADT
ADT
$5.51B
| $3.02M | ﹤0.01% |
372,907
+202,549
| +119% | +$1.87M |
|
|
TMHC
3394
DELISTED
Taylor Morrison
TMHC
| $3.01M | ﹤0.01% |
116,817
+18,389
| +19% | +$487K |
|
3395
Laureate Education
LAUR
$5.34B
| $3.01M | ﹤0.01% |
176,977
+63,456
| +56% | +$997K |
|
3396
Prosperity Bancshares
PB
$8.69B
| $3.01M | ﹤0.01% |
42,275
-53,122
| -56% | -$3.68M |
|
|
PIAI.U
3397
DELISTED
Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share
PIAI.U
| $3.01M | ﹤0.01% |
299,200
| – | – |
|
3398
PUT
American Well
AMWL
$203M
| $3.01M | ﹤0.01% |
16,500
+1,500
| +10% | +$325K |
|
3399
First Hawaiian
FHB
$3.14B
| $3.01M | ﹤0.01% |
102,424
-19,367
| -16% | -$538K |
|
3400
Weyerhaeuser
WY
$17B
| $3M | ﹤0.01% |
84,382
-417,960
| -83% | -$14.6M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.